Register for Pediatric Patients With Antiphospholipid Syndrome (APS): European Project Extended Internationally Study
Part of paid clinical trials in Sacramento, California.
- Sponsor
- University of California, Davis
- Study ID
- NCT00616317
- Status
- Recruiting
Conditions
- Antiphospholipid Syndrome
Eligibility Criteria
- Sex
- ALL
- Age
- 1 Minute - 18 Years
- Healthy Volunteers
- Not accepted
Study Details
The purpose of this study is to gather information about causes and treatment of Antiphospholipid Syndrome.
Key Dates
- Start date
- Sep 30, 2006
- Status verified
- Dec 2025
- Primary completion
- Jan 31, 2040
- Completion
- Jan 31, 2040
Study Design
- Enrollment
- 50 participants (estimated)
Primary Outcome Measure
Long term survival [ Time Frame: 10 year ]
Central Contacts
- Lavjay Butani(916) 734-8118
Locations (1)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| UC Davis Medical Center | Sacramento | California | 95817 | - |
Find similar trials in Sacramento, CA
By research site
Related Studies
- Predictors of Pregnancy Outcome in Systemic Lupus Erythematosus (SLE) and Antiphospholipid Syndrome (APS)Recruiting · Hospital for Special Surgery, New York · Chicago, Illinois
- Genetic Risk Factors Associated With Antiphospholipid Antibody SyndromeRecruiting · Duke University · Durham, North Carolina
- Rheumatology Patient Registry and BiorepositoryRecruiting · Yale University · New Haven, Connecticut